Proof-of-Concept Study in Cancer Patients to Assess Efficacy of Elsiglutide in Preventing Chemotherapy-Induced Diarrhea
Ontology highlight
ABSTRACT: The main objective of this study will be to obtain data on the efficacy of elsiglutide in preventing Chemotherapy Induced Diarrhea (CID) in patients with colorectal cancer receiving 5-FU based chemotherapy (FOLFOX4 or FOLFIRI regimen) in comparison to placebo.
DISEASE(S): Kemoterápia Okozta Hasmenés,Chemotherapy Induced Diarrhea,Diarrhea Post Chemotherapy,Diarrhea
PROVIDER: 2121148 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA